Wafik S. El-Deiry: Discussing collaboration between Iylon Precision Oncology and the WIN Consortium
Sendurai Mani shared a post by Wafik S. El-Deiry on LinkedIn:
“Thank you, Wafik S. El-Deiry for always thinking outside the box.
John Tarantino and I truly enjoyed meeting you and learning about your big vision for WIN Consortium in cancer personalized medicine.
We are looking forward to working with you, Razelle Kurzrock, Catherine Bresson, Fanny Wunder, and the rest of the WIN team and finding ways to make a positive impact.”
Quoting Wafik S. El-Deiry’s post:
“Delighted to speak with Sendurai Mani and John Tarantino this morning about ways Iylon Precision Oncology could collaborate with the WIN Consortium in cancer personalized medicine in advancing the field of Precision Oncology. ”
Wafik S. El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals. He is the Editor in Chief at Oncotarget. Dr. El-Deiry discovered p21(WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response. Dr. El-Deiry’s research is focused on mechanisms of therapy resistance with major efforts in drug discovery and development.
Sendurai A. Mani is an Indian-American oncologist and molecular biologist. Currently holding the Dean’s Chair for Translational Oncology at Brown University Warren Alpert Medical School, Dr. Mani also serves as the Associate Director for Translational Oncology at the Legorreta Cancer Center at Alpert Medical School.
Dr. Mani’s research focuses on finding the mechanisms driving cancer metastasis and therapy resistance, particularly in breast cancer. He is renowned for his discovery of cancer stem cells and their role in tumor progression and treatment resistance.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023